Safety and Tolerability Study of Lu AF11167 After Repeated Dosing in Patients With Schizophrenia
Clinical trial NCT02202213 · COMPLETED
Trial details
- NCT number
- NCT02202213
- Sponsor
- H. Lundbeck A/S
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-10-01
- Primary completion
- 2015-02-01
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.